Business Wire - November 13, 2008
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
DNA Diagnostics: Technologies and Global Markets
http://www.reportlinker.com/p096610/DNA-Diagnostics-Technologies -and-Global-Markets.html
(Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
Decribes the major technologies for analyzing DNA in a clinic setting, including DNA microarrays, PCR-based assays, ISH diagnostics, and LOAC diagnostics Offers the current global market status for DNA diagnostics, with trends and forecasts for growth over the next 5 years Analyzes differential applications within the categories of diagnostic technologies Discusses government regulatory provisions that govern activities in the industry Includes company profiles.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
BCC ONLINE SERVICES
DISCLAIMER
SUMMARY
SUMMARY TABLE GLOBAL MARKET FOR CLINICAL DNA DIAGNOSTICS, BY SEGMENT, THROUGH 2013 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR CLINICAL DNA DIAGNOSTICS, BY SEGMENT, 2008-2013 ($ MILLIONS)
OVERVIEW
INTRODUCTION TO GENOMIC DIAGNOSTICS
INTRODUCTION TO GENOMIC … (CONTINUED)
INTRODUCTION TO GENOMIC … (CONTINUED)
EXPRESSION PROFILING AND DISEASE
EXPRESSION PROFILING AND INFECTIOUS DISEASE
DNA SEQUENCING FOR GENOTYPING AND DIAGNOSIS
CLINICAL PHARMACOLOGY
MUTATION DETECTION AND GENOTYPING FOR SPECIFIC GENES
IDENTIFICATION OF NEW DISEASE GENES
REGULATORY FACTORS
SUCCESSES AND LIMITATIONS OF GENETIC TESTING
REGULATORY POLICIES
FOOD AND DRUG ADMINISTRATION: NEW GUIDELINES
INTERNAL STANDARDS FOR DNA DIAGNOSTICS
INSURANCE
INSURANCE (CONTINUED)
MARKETING DIRECTLY TO CONSUMERS
MARKET FOR CLINICAL DNA DIAGNOSTICS, BY PRODUCT
TABLE 1 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS PRODUCTS, THROUGH 2013 ($ MILLIONS)
FIGURE 1 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS PRODUCTS, 2005-2013 ($ MILLIONS)
FIGURE 2 GLOBAL DNA DIAGNOSTICS MARKET, BY PRODUCT SHARE, 2008 (%)
FIGURE 2 (CONTINUED)
FIGURE 3 GLOBAL DNA DIAGNOSTICS MARKET, BY PRODUCT SHARE, 2013 (%)
MARKET FOR CLINICAL DNA DIAGNOSTICS BY TECHNOLOGY, THROUGH 2013
MICROARRAY DIAGNOSTICS
TABLE 2 GLOBAL MARKET FORECAST FOR DNA MICROARRAY PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
FIGURE 4 GLOBAL MARKET FORECAST FOR DNA MICROARRAY PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
PLANAR DNA MICROARRAYS
TABLE 3 MAJOR SUPPLIERS OF PLANAR DNA MICROARRAYS
BEAD MICROARRAYS
TABLE 4 MAJOR SUPPLIERS OF BEAD MICROARRAYS
ELECTRONIC MICROARRAYS
EMERGING TECHNOLOGY: NANOPARTICLE ARRAYS
Verigene (Nanosphere, Chicago, IL)
Nanoplex Technologies (Mountain View, CA)
PCR-BASED DIAGNOSTICS
TABLE 5 GLOBAL MARKET FORECAST FOR PCR-BASED PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
FIGURE 5 GLOBAL MARKET FORECAST FOR ISH PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
TABLE 6 MAJOR SUPPLIERS OF PCR-BASED ASSAYS
PCR-BASED TECHNOLOGIES FOR DIAGNOSTICS
LightCycler (Roche Molecular Systems, Pleasanton, CA)
TaqMan DNA probes (Applied Biosystems, Foster City,
CA)
Invader (Third Wave Technologies, Madison, WI)
Tag-It Mutation Assay (Tm Bioscience)
ReadIt Depolymerization Assay (Promega, Madison, WI)
IN SITU HYBRIDIZATION DIAGNOSTICS
TABLE 7 GLOBAL MARKET FORECAST FOR ISH PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
FIGURE 6 GLOBAL MARKET FORECAST FOR ISH PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
INTRODUCTION TO ISH PRODUCTS
INTRODUCTION TO ISH PRODUCTS (CONTINUED)
TECHNOLOGY
FIBER FISH
HER-2 FISH TESTING
IMMUNOHISTOCHEMISTRY
TABLE 8 COMPARISON OF FISH AND IHC PRODUCTS FOR DIAGNOSTIC TESTING
EMERGING TECHNOLOGIES IN IN SITU HYBRIDIZATION
BIOCHIPS/LAB-ON-A-CHIP
THE MARKET FOR LAB-ON-A-CHIP PRODUCTS
TABLE 9 GLOBAL MARKET FORECAST FOR LOAC PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
FIGURE 7 GLOBAL MARKET FORECAST FOR LOAC PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
The Market for Lab-on-a-… (Continued)
MICROFLUIDIC DEVICES
Microfluidic Devices (Continued)
EMERGING DIAGNOSTIC ASSAYS
THE TREND TOWARDS SINGLE CELL MEASUREMENTS
Genetic Typing of Single Cells
Single Cell Sequencing
Copy Number Variations in Single Cells
Combined Immunotyping and Single Cell Expression Analysis
DIAGNOSING THE EPIGENOME
MARKETS BY APPLICATION
OVERALL MARKET FOR DNA DIAGNOSTICS BY APPLICATION
TABLE 10 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2013 ($ MILLIONS)
FIGURE 8 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATION, 2005-2013 ($ MILLIONS)
FIGURE 9 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATION, 2008 (%)
FIGURE 10 GLOBAL DNA DIAGNOSTICS MARKET FORECAST BY APPLICATION, 2013 ($ MILLIONS)
PRENATAL AND NEWBORN GENETIC SCREENING
TABLE 11 GLOBAL MARKET FORECAST FOR PRENATAL AND NEWBORN DNA SCREENING BY PRODUCT, THROUGH 2013 ($ MILLIONS)
FIGURE 11 GLOBAL MARKET FORECAST FOR PRENATAL AND NEWBORN DNA SCREENING BY PRODUCT, 2005-2013 ($ MILLIONS)
CARRIER SCREENING
Prenatal Diagnostic Testing
Amniocentesis
Chorionic Villus Sampling (CVS)
Genetic Counseling
PREIMPLANTATION DIAGNOSIS,
NEWBORN SCREENING
TABLE 12 NEWBORN SCREENING RECOMMENDED BY THE AMERICAN COLLEGE OF MEDICAL GENETICS
TABLE 12 (CONTINUED)
TABLE 13 STATES WITH MANDATED NEWBORN SCREENING FOR AT LEAST 20 OF THE RECOMMENDED ACMG DISORDERS
Prenatal and Post-Natal Genetic Testing: An Example
INFECTIOUS DISEASE DIAGNOSTICS
TABLE 14 GLOBAL MARKET FORECAST FOR INFECTIOUS DISEASE DNA DIAGNOSTICS BY PRODUCT, THROUGH 2013 ($ MILLIONS)
FIGURE 12 GLOBAL MARKET FORECAST FOR INFECTIOUS DISEASE DNA DIAGNOSTICS BY PRODUCT, 2005-2013 ($ MILLIONS)
HIV/AIDS
TABLE 15 MAJOR SUPPLIERS OF HIV GENOTYPIC RESISTANCE TESTS
PRODUCTS
Monogram Biosciences (formerly ViroLogic)
PhenoSense GT
PhenoSense HIV
GeneSeq HIV
PhenoSense Entry
Replication Capacity (RC)
PHARMACOGENOMICS AND HIV THERAPY
ONCOLOGY DIAGNOSTICS AND HISTOPATHOLOGY
TABLE 16 GLOBAL MARKET FORECAST FOR ONCOLOGY DNA DIAGNOSTICS BY PRODUCT, THROUGH 2013 ($ MILLIONS)
FIGURE 13 GLOBAL MARKET FORECAST FOR ONCOLOGY DNA DIAGNOSTICS BY PRODUCT, 2005-2013 ($ MILLIONS)
Leukemias
Chronic Myeloid Leukemia (CML)
Genetic Marker of CML
Gleevec
IDENTITY DIAGNOSTICS, PATERNITY AND FORENSICS
TABLE 17 GLOBAL MARKET FORECAST FOR IDENTITY AND PATERNITY DNA DIAGNOSTICS BY PRODUCT, THROUGH 2013 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET FORECAST FOR IDENTITY AND PATERNITY DNA DIAGNOSTICS BY PRODUCT, 2005-2013 ($ MILLIONS
PATERNITY TESTING
Technology
Pricing and Target Consumers
Accreditation
Legal Issues
International News
International News (Continued)
TABLE 18 MAJOR PLAYERS IN PATERNITY TEST SERVICES
Veterinary Identity Testing
OTHER APPLICATIONS
TABLE 19 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS IN OTHER CLINICAL APPLICATIONS, BY PRODUCT, THROUGH 2013 ($ MILLIONS)
FIGURE 15 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS IN OTHER APPLICATIONS BY PRODUCT, 2005-2013 ($ MILLIONS)
PHARMACOGENOMICS DIAGNOSTIC TESTING
DRUG METABOLISM
P450 ISOZYMES AND PHARMACEUTICALS
TABLE 20 DRUG METABOLISM AND CYTOCHROME P450 ISOZYMES
P450 Isozyme CYP3A
P450 Isozyme CYP2D6
P450 Isozyme CYP2C9
P450 Isozyme 2C19
P450 Isozyme 1A2
P450 DIAGNOSTIC TESTING
TABLE 21 MAJOR SUPPLIERS OF CYTOCHROME P450 TESTING FOR RESEARCH PURPOSES
TABLE 21 (CONTINUED)
Presymptomatic Testing
PATENT ANALYSIS
PATENTS BY TECHNOLOGY
TABLE 22 DNA DIAGNOSTICS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2005-JANUARY 2008
FIGURE 16 DNA DIAGNOSTICS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2005-JANUARY 2008 (%)
PATENTS BY REGION
TABLE 23 DNA DIAGNOSTICS, ISSUED PATENTS BY REGION, JANUARY 2005-JANUARY 2008
TABLE 23 (CONTINUED)
PATENTS BY MEDICAL APPLICATION
TABLE 24 DNA DIAGNOSTICS, ISSUED PATENTS BY PRIMARY APPLICATION, JANUARY 2005-JANUARY 2008
FIGURE 17 DNA DIAGNOSTICS, ISSUED PATENTS BY PRIMARY APPLICATION, JANUARY 2005-JANUARY 2008 (%)
SIGNIFICANT PATENT NEWS
KEY PATENT ACTIVITY IN PCR
KEY PATENT ACTIVITY IN BREAST CANCER TYPING
RECENT KEY PATENTS IN DNA DIAGNOSTICS
Recent Key Patents in DNA … (Continued)
Recent Key Patents in DNA … (Continued)
Recent Key Patents in DNA … (Continued)
INDUSTRY STRUCTURE
TABLE 25 MARKET SHARE OF COMPANIES INVOLVED IN MICROARRAY DIAGNOSTICS, 2008 ($ MILLIONS)
TABLE 26 MARKET SHARE OF COMPANIES INVOLVED IN PCR DIAGNOSTICS, 2008 ($ MILLIONS)
TABLE 27 MARKET SHARE OF COMPANIES INVOLVED IN ISH DIAGNOSTICS, 2008 ($ MILLIONS)
TABLE 28 MARKET SHARE OF COMPANIES INVOLVED IN LAB-ONA-CHIP DIAGNOSTICS, 2008 ($ MILLIONS)
INDUSTRY STRUCTURE (CONTINUED)
COMPANY PROFILES
454 LIFE SCIENCES
ABBOTT DIAGNOSTICS
ADVANDX
AFFYMETRIX, INC
AGILENT TECHNOLOGIES INC.
AMBION INC
APPLIED BIOSYSTEMS GROUP
APPLIED BIOSYSTEMS GROUP (CONTINUED)
APPLIED IMAGING CORP.
AUTOGENOMICS, INC.
BAYER DIAGNOSTICS
BECKMAN COULTER, INC
BECTON DICKINSON
BIOMERIEUX SA
BIOMICRO SYSTEMS, INC.
BIO-RAD LABORATORIES
CALIPER LIFE SCIENCES, INC
CALLIDA GENOMICS INC./HYSEQ
CELERA DIAGNOSTICS
CEPHEID
CHEMICON INTERNATIONAL, INC., DIVISION OF SEROLOGICALS CORP.
CHIRON CORP
CLINICAL DATA, INC
CURAGEN CORP
DECODE GENETICS
DIGENE CORP
DNA DIAGNOSTICS CENTER
EUROGENTEC
EXACT SCIENCES CORP.
FOCUS DIAGNOSTICS
GE HEALTHCARE
GEN-PROBE INCORPORATED
GEN-PROBE INCORPORATED (CONTINUED)
ILLUMINA
INVITROGEN DYNAL AS
LABORATORY CORPORATION OF AMERICA (LABCORP)
LUMINEX CORP
MICRONICS
MONOGRAM BIOSCIENCES, INC.
MYRIAD GENETICS
NANOGEN INC.
ORCHID BIOSCIENCES
OXFORD GENE TECHNOLOGY IP LTD
PRODESSE INC.
PYROSEQUENCING/BIOTAGE AB
QIAGEN N.V
QUEST DIAGNOSTICS
ROCHE (F. HOFFMANN-LA ROCHE LTD)
SEQUENOM INC.
STRATAGENE CORP. / HYCOR BIOMEDICAL INC
SORENSON GENOMICS, INC
THERMO FISHER SCIENTIFIC, INC
THIRD WAVE TECHNOLOGIES, INC
TRANSGENOMIC INC.
U.S. GENOMICS
VIROLOGIC, INC.
WYETH-AYERST, INC.
WYETH-AYERST, INC. (CONTINUED)
LIST OF TABLES
SUMMARY TABLE GLOBAL MARKET FOR CLINICAL DNA DIAGNOSTICS, BY SEGMENT, THROUGH 2013 ($ MILLIONS)
TABLE 1 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS PRODUCTS, THROUGH 2013 ($ MILLIONS)
TABLE 2 GLOBAL MARKET FORECAST FOR DNA MICROARRAY PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
TABLE 3 MAJOR SUPPLIERS OF PLANAR DNA MICROARRAYS
TABLE 4 MAJOR SUPPLIERS OF BEAD MICROARRAYS
TABLE 5 GLOBAL MARKET FORECAST FOR PCR-BASED PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
TABLE 6 MAJOR SUPPLIERS OF PCR-BASED ASSAYS
TABLE 7 GLOBAL MARKET FORECAST FOR ISH PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
TABLE 8 COMPARISON OF FISH AND IHC PRODUCTS FOR DIAGNOSTIC TESTING
TABLE 9 GLOBAL MARKET FORECAST FOR LOAC PRODUCTS IN CLINICAL DIAGNOSTICS, THROUGH 2013 ($ MILLIONS)
TABLE 10 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATION, THROUGH 2013 ($ MILLIONS)
TABLE 11 GLOBAL MARKET FORECAST FOR PRENATAL AND NEWBORN DNA SCREENING BY PRODUCT, THROUGH 2013 ($ MILLIONS)
TABLE 12 NEWBORN SCREENING RECOMMENDED BY THE AMERICAN COLLEGE OF MEDICAL GENETICS
TABLE 13 STATES WITH MANDATED NEWBORN SCREENING FOR AT LEAST 20 OF THE RECOMMENDED ACMG DISORDERS
TABLE 14 GLOBAL MARKET FORECAST FOR INFECTIOUS DISEASE DNA DIAGNOSTICS BY PRODUCT, THROUGH 2013 ($ MILLIONS)
TABLE 15 MAJOR SUPPLIERS OF HIV GENOTYPIC RESISTANCE TESTS
TABLE 16 GLOBAL MARKET FORECAST FOR ONCOLOGY DNA DIAGNOSTICS BY PRODUCT, THROUGH 2013 ($ MILLIONS)
TABLE 17 GLOBAL MARKET FORECAST FOR IDENTITY AND PATERNITY DNA DIAGNOSTICS BY PRODUCT, THROUGH 2013 ($ MILLIONS)
TABLE 18 MAJOR PLAYERS IN PATERNITY TEST SERVICES
TABLE 19 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS IN OTHER CLINICAL APPLICATIONS, BY PRODUCT, THROUGH 2013 ($ MILLIONS)
TABLE 20 DRUG METABOLISM AND CYTOCHROME P450 ISOZYMES
TABLE 21 MAJOR SUPPLIERS OF CYTOCHROME P450 TESTING
FOR RESEARCH PURPOSES
TABLE 22 DNA DIAGNOSTICS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2005-JANUARY 2008
TABLE 23 DNA DIAGNOSTICS, ISSUED PATENTS BY REGION, JANUARY 2005-JANUARY 2008
TABLE 24 DNA DIAGNOSTICS, ISSUED PATENTS BY PRIMARY APPLICATION, JANUARY 2005-JANUARY 2008
TABLE 25 MARKET SHARE OF COMPANIES INVOLVED IN MICROARRAY DIAGNOSTICS, 2008 ($ MILLIONS)
TABLE 26 MARKET SHARE OF COMPANIES INVOLVED IN PCR DIAGNOSTICS, 2008 ($ MILLIONS)
TABLE 27 MARKET SHARE OF COMPANIES INVOLVED IN ISH DIAGNOSTICS, 2008 ($ MILLIONS)
TABLE 28 MARKET SHARE OF COMPANIES INVOLVED IN LAB-ON-ACHIP DIAGNOSTICS, 2008 ($ MILLIONS)
LIST OF FIGURES
SUMMARY FIGURE GLOBAL MARKET FOR CLINICAL DNA DIAGNOSTICS, BY SEGMENT, 2008-2013 ($ MILLIONS)
FIGURE 1 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS PRODUCTS, 2005-2013 ($ MILLIONS)
FIGURE 2 GLOBAL DNA DIAGNOSTICS MARKET, BY PRODUCT SHARE, 2008 (%)
FIGURE 3 GLOBAL DNA DIAGNOSTICS MARKET, BY PRODUCT SHARE, 2013 (%)
FIGURE 4 GLOBAL MARKET FORECAST FOR DNA MICROARRAY PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
FIGURE 5 GLOBAL MARKET FORECAST FOR ISH PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
FIGURE 6 GLOBAL MARKET FORECAST FOR ISH PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
FIGURE 7 GLOBAL MARKET FORECAST FOR LOAC PRODUCTS IN CLINICAL DIAGNOSTICS, 2005-2013 ($ MILLIONS)
FIGURE 8 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATION, 2005-2013 ($ MILLIONS)
FIGURE 9 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATION, 2008 (%)
FIGURE 10 GLOBAL DNA DIAGNOSTICS MARKET FORECAST BY APPLICATION, 2013 ($ MILLIONS)
FIGURE 11 GLOBAL MARKET FORECAST FOR PRENATAL AND NEWBORN DNA SCREENING BY PRODUCT, 2005-2013 (MILLIONS)
FIGURE 12 GLOBAL MARKET FORECAST FOR INFECTIOUS DISEASE DNA DIAGNOSTICS BY PRODUCT, 2005-2013 ($ MILLIONS)
FIGURE 13 GLOBAL MARKET FORECAST FOR ONCOLOGY DNA DIAGNOSTICS BY PRODUCT, 2005-2013 ($ MILLIONS)
FIGURE 14 GLOBAL MARKET FORECAST FOR IDENTITY AND PATERNITY DNA DIAGNOSTICS BY PRODUCT, 2005-2013
($ MILLIONS
FIGURE 15 GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS IN OTHER APPLICATIONS BY PRODUCT, 2005-2013 ($ MILLIONS
FIGURE 16 DNA DIAGNOSTICS, ISSUED PATENTS BY TECHNOLOGY, JANUARY 2005-JANUARY 2008 ($ MILLIONS)
FIGURE 17 DNA DIAGNOSTICS, ISSUED PATENTS BY PRIMARY APPLICATION, JANUARY 2005-JANUARY 2008 (%)
To order this report:
DNA Diagnostics: Technologies and Global Markets
http://www.reportlinker.com/p096610/DNA-Diagnostics-Technologies -and-Global-Markets.html
(Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
More market research reports here!
Reportlinker
Nicolas: nbo@reportlinker.com
US:
(805)-652-2626
Intl: +1 805-652-2626
081113
BW081125
Copyright © 2008 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .